TURNING GENOMICS INTO BREAKTHROUGH DRUGS

Array BioPharma Inc.

Application Filed: 2001-03-29
Trademark Application Details
Trademark Logo TURNING GENOMICS INTO BREAKTHROUGH DRUGS

Mark For: TURNING GENOMICS INTO BREAKTHROUGH DRUGS™ trademark registration is intended to cover the categories of scientific or medical research reagents for drug discovery and design; chemicals in the nature of building blocks for use in the development research of pharmaceuticals and pharmaceutical-related products; chemical compounds and chemical combinatorial libraries for use in pharmaceutical drug discovery, research and analysis, and for use in the manufacture of pharmaceutical drugs. [all]

Status

2022-09-04 UTC
DEAD APPLICATION Refused Dismissed or Invalidated
This trademark application was refused, dismissed, or invalidated by the Office and this application is no longer active.


Research OneLook Acronym Finder
Serial Number76232657
Mark Literal ElementsTURNING GENOMICS INTO BREAKTHROUGH DRUGS
Mark Drawing Type1 - TYPESET WORD(S) /LETTER(S) /NUMBER(S)
Mark TypeTRADEMARK. SERVICE MARK
Standard Character ClaimNo
RegisterPRINCIPAL
Current LocationTMEG LAW OFFICE 101 - EXAMINING ATTORNEY ASSIGNED 2005-07-07
Basis1(a)
Class StatusACTIVE
Primary US Classes
  • 001: Raw or Partly Prepared Materials
  • 005: Adhesives
  • 006: Chemicals and Chemical Compositions
  • 010: Fertilizers
  • 026: Measuring and Scientific Appliances
  • 046: Foods and Ingredients of Foods
Primary International Class
  • 001 - Primary Class
  • (Chemicals) Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins, unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry.
Filed UseNo
Current UseYes
Intent To UseYes
Filed ITUYes
44D FiledNo
44E CurrentNo
66A CurrentNo
Current BasisNo
No BasisNo
Attorney NamePatrick K. Perrin
Law Office AssignedL10
Employee NameIM, JEAN H

Timeline

2000-10-01Date of First Use
2000-10-01Date of Use In Commerce
2001-03-29Application Filed
2003-04-29Published
2003-04-29Published for Opposition
2005-06-07Abandon
2005-07-07Location: TMEG LAW OFFICE 101 - EXAMINING ATTORNEY ASSIGNED
2005-07-07Status: Abandoned because the applicant failed to respond or filed a late response to an Office action. To view all documents in this fi
2005-07-07Status: Dead/Abandoned
2018-07-08Transaction Date

Trademark Parties (Applicants & Owners)

Party: Array BioPharma Inc.
Address1885 33rd Street Boulder, COLORADO UNITED STATES 80301
Legal Entity TypeCorporation
Legal Entity StateDELAWARE

Attorney of Record

PATRICK K. PERRIN
HOGAN & HARTSON LLP
BOX INTELLECTUAL PROPERTY
8300 GREENSBORO DR STE 1100
MCLEAN, VIRGINIA 22102

Good, Services, and Codes

(ABANDONED)
IC 001. US 001 005 006 010 026 046. G & S: Scientific or medical research reagents for drug discovery and design; chemicals in the nature of building blocks for use in the development research of pharmaceuticals and pharmaceutical-related products; chemical compounds and chemical combinatorial libraries for use in pharmaceutical drug discovery, research and analysis, and for use in the manufacture of pharmaceutical drugs. FIRST USE: 20001001. FIRST USE IN COMMERCE: 20001001(ABANDONED)
IC 042. US 100 101. G & S: Chemical and pharmaceutical research and development for others; drug discovery and design services, namely identifying and designing chemical compounds for use in pharmaceuticals; process research for drug candidates for others; medicinal and analytical chemistry services. FIRST USE: 20001001. FIRST USE IN COMMERCE: 20001001

International Codes:1
U.S. Codes:001,005,006,010,026,046
International Codes:42
U.S. Codes:100,101
Type CodeType
GS0011Scientific or medical research reagents for drug discovery and design; chemicals in the nature of building blocks for use in the development research of pharmaceuticals and pharmaceutical-related products; chemical compounds and chemical combinatorial libraries for use in pharmaceutical drug discovery, research and analysis, and for use in the manufacture of pharmaceutical drugs

Trademark Filing History

DescriptionDateProceeding Number
ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND2005-07-07
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE2005-07-07
SU - NON-FINAL ACTION - WRITTEN2004-12-0776615
NON-FINAL ACTION MAILED2004-12-07
PREVIOUS ALLOWANCE COUNT WITHDRAWN2004-09-07
LAW OFFICE REGISTRATION REVIEW COMPLETED2004-08-1676243
ASSIGNED TO LIE2004-08-0376243
ASSIGNED TO LIE2004-07-3076243
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED2003-12-10
ASSIGNED TO EXAMINER2003-11-1976615
CASE FILE IN TICRS2003-11-18
STATEMENT OF USE PROCESSING COMPLETE2003-11-07
TEAS STATEMENT OF USE RECEIVED2003-10-30
USE AMENDMENT FILED2003-10-29
NOA MAILED - SOU REQUIRED FROM APPLICANT2003-07-22
PUBLISHED FOR OPPOSITION2003-04-29
NOTICE OF PUBLICATION2003-04-09
APPROVED FOR PUB - PRINCIPAL REGISTER2003-03-04
PAPER RECEIVED2003-01-06
CORRESPONDENCE RECEIVED IN LAW OFFICE2003-01-06
FINAL REFUSAL MAILED2002-07-16
CORRESPONDENCE RECEIVED IN LAW OFFICE2001-12-18
NON-FINAL ACTION MAILED2001-07-18
ASSIGNED TO EXAMINER2001-07-1276615

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed